Showing results (141-150 of 226) with videos related to
Sort By:
Pageof 23
Aging Cell|July 12, 2018
Plasma proteomic signature of age in healthy humansToshiko Tanaka, Angelique Biancotto, Ruin Moaddel, et al.Psychopharmacology|August 18, 2018
Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjectsRuin Moaddel, Michelle Shardell, Mohammed Khadeer, et al.Talanta|September 30, 2010
A parallel chiral-achiral liquid chromatographic method for the determination of the stereoisomers of ketamine and ketamine metabolites in the plasma and urine of patients with complex regional pain syndromeRuin Moaddel, Swarajya Lakshmi Vattem Venkata, Mary J Tanga, et al.The Journal of Pharmacology and Experimental Therapeutics|July 30, 2016
Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine TransportersAdem Can, Panos Zanos, Ruin Moaddel, et al.Acta Neuropathologica|April 26, 2020
Biological sex and DNA repair deficiency drive Alzheimer's disease via systemic metabolic remodeling and brain mitochondrial dysfunctionTyler G Demarest, Vijay R Varma, Darlene Estrada, et al.Proceedings of the National Academy of Sciences of the United States of America|March 15, 2019
(2R,6R)-hydroxynorketamine exerts mGlu2 receptor-dependent antidepressant actionsPanos Zanos, Jaclyn N Highland, Brent W Stewart, et al.Ebiomedicine|May 24, 2016
Child Stunting is Associated with Low Circulating Essential Amino AcidsRichard D Semba, Michelle Shardell, Fayrouz A Sakr Ashour, et al.Aging Cell|February 6, 2019
Low plasma lysophosphatidylcholines are associated with impaired mitochondrial oxidative capacity in adults in the Baltimore Longitudinal Study of AgingRichard D Semba, Pingbo Zhang, Fatemeh Adelnia, et al.Journal of Huntington'S Disease|January 28, 2020
Baseline Variables Associated with Functional Decline in 2CARE, A Randomized Clinical Trial in Huntington's DiseaseAndrew McGarry, Michael P McDermott, Karl Kieburtz, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 8, 2020
Correction: Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depressionCristan A Farmer, Jessica R Gilbert, Ruin Moaddel, et al.Pageof 23